Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a centre in south-east Asia

ABSTRACT This study reviewed 1787 episodes of peritoneal dialysis (PD)-related peritonitis in 544 patients between 1994 and 2003. The overall rate of peritonitis was 0.68 episodes/year of PD, but decreased from 1.10 to 0.46 episodes/year between 1994 and 2003. The incidence of peritonitis caused by coagulase-negative staphylococci declined between 1994 and 1998 from 0.21 to 0.06 episodes/year of PD, coinciding with a reduction in the use of spike PD sets. There was a 60.1% response rate to antibiotics throughout the period, but the percentage of cases that required modification of the initial empirical antibiotic regimen rose from 13.6% to 58.7%, indicating that treatment should be individualised.

[1]  S. Vas Peritonitis during CAPD: A Mixed Bag , 1980 .

[2]  B. Piraino,et al.  Methicillin-resistant staphylococcal infections in an outpatient peritoneal dialysis program. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  P. Li,et al.  Use of Intraperitoneal Cefepime as Monotherapy in Treatment of CAPD Peritonitis , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[4]  Zhong-Gao Xu,et al.  Changes in Causative Organisms and Their Antimicrobial Susceptibilities in Capd Peritonitis: A Single Center's Experience over one Decade , 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[5]  I. Kobayashi,et al.  Identification in Methicillin-Susceptible Staphylococcus hominis of an Active Primordial Mobile Genetic Element for the Staphylococcal Cassette Chromosome mec of Methicillin-Resistant Staphylococcus aureus , 2003, Journal of bacteriology.

[6]  A. Tzamaloukas,et al.  Peritoneal dialysis in the next millennium. , 2000, Advances in renal replacement therapy.

[7]  John D. Turnidge,et al.  Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community , 2002, Journal of Clinical Microbiology.

[8]  S. Ouyang,et al.  Type 1 Capsule Genes of Staphylococcus aureus Are Carried in a Staphylococcal Cassette Chromosome Genetic Element , 2002, Journal of bacteriology.

[9]  B. C. Kwan,et al.  Cefazolin plus Ceftazidime versus Imipenem / Cilastatin Monotherapy for Treatment of Capd Peritonitis — a Randomized Controlled Trial , 2004, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[10]  I. Phillips,et al.  The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis. , 1989, The Journal of hospital infection.

[11]  D. Harmsen,et al.  Emergence of methicillin-resistant Staphylococcus aureus with Panton–Valentine leukocidin genes in central Europe , 2004, European Journal of Clinical Microbiology and Infectious Diseases.

[12]  P. Li,et al.  Importance of dialysis adequacy in mortality and morbidity of chinese CAPD patients. , 2000, Kidney international.

[13]  R. Giroux,et al.  New Real-Time PCR Assay for Rapid Detection of Methicillin- Resistant Staphylococcus aureus Directly from Specimens Containing a Mixture of Staphylococci , 2004, Journal of Clinical Microbiology.

[14]  W. So,et al.  Comparisons of Y-Set Disconnect System (Ultraset) versus Conventional Spike System in Uremic Patients on Capd: Outcome and Cost Analysis , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[15]  C. Walsh,et al.  The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA) , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  강신욱 Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: A single center's experience over one decade , 2004 .

[17]  J. Winchester,et al.  Ten years' experience with continuous ambulatory peritoneal dialysis. , 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  K. Lai,et al.  Imipenem/cilastatin sodium in the treatment of continuous ambulatory peritoneal dialysis-associated peritonitis. , 1994, American Journal of Nephrology.

[19]  K. Chow,et al.  Conservative management of polymicrobial peritonitis complicating peritoneal dialysis--a series of 140 consecutive cases. , 2002, The American journal of medicine.

[20]  A. Levey,et al.  Continuous Peritoneal Dialysis for Chronic Renal Failure , 1982, Medicine.

[21]  G. Barnaud,et al.  Impact of screening for MRSA carriers at hospital admission on risk-adjusted indicators according to the imported MRSA colonization pressure. , 2005, The Journal of hospital infection.

[22]  C. Szeto,et al.  Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: a randomized prospective multicenter study. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  K. Chow,et al.  Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: a review of 104 cases. , 2001, Kidney international.

[24]  B. Piraino,et al.  Adult Peritoneal Dialysis-Related Peritonitis Treatment Recommendations: 2000 Update , 2000, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.